These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9219790

  • 1. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G.
    Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
    [Abstract] [Full Text] [Related]

  • 2. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases].
    Miheller P, Tóth M, Molnár E, Zágoni T, Rácz K, Tulassay Z.
    Orv Hetil; 2001 Jul 22; 142(29):1557-60. PubMed ID: 11494747
    [Abstract] [Full Text] [Related]

  • 3. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep 22; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 4. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan 22; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
    Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R.
    Exp Clin Endocrinol; 1994 Jan 22; 102(1):44-9. PubMed ID: 8005208
    [Abstract] [Full Text] [Related]

  • 6. Biochemical markers and bone densitometry in inflammatory bowel disease.
    Ledro Cano D, Torres Domínguez Y, Castro Laria L, Sáenz Dana M, Herrerías Esteban JM, Herrerías Gutiérrez JM.
    Rev Esp Enferm Dig; 2000 Sep 22; 92(9):595-600. PubMed ID: 11138241
    [Abstract] [Full Text] [Related]

  • 7. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA, Hamdy NA.
    Scand J Gastroenterol Suppl; 2006 Sep 22; (243):59-64. PubMed ID: 16782623
    [Abstract] [Full Text] [Related]

  • 8. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D.
    Am J Gastroenterol; 2000 Mar 22; 95(3):699-704. PubMed ID: 10710060
    [Abstract] [Full Text] [Related]

  • 9. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.
    J Bone Miner Res; 1995 Feb 22; 10(2):250-6. PubMed ID: 7754804
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC, Huijberts MS, Schoon EJ, Geusens P, de Vries J, Menheere PP, van der Veer E, Wolffenbuttel BH, Stockbrugger RW, Dumitrescu B, Nieuwenhuijzen Kruseman AC.
    Eur J Gastroenterol Hepatol; 2008 Aug 22; 20(8):740-7. PubMed ID: 18617778
    [Abstract] [Full Text] [Related]

  • 11. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A.
    Gastroenterol Clin Biol; 2003 Oct 22; 27(10):901-7. PubMed ID: 14631305
    [Abstract] [Full Text] [Related]

  • 12. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease.
    Nakajima S, Iijima H, Egawa S, Shinzaki S, Kondo J, Inoue T, Hayashi Y, Ying J, Mukai A, Akasaka T, Nishida T, Kanto T, Tsujii M, Hayashi N.
    Nutrition; 2011 Oct 22; 27(10):1023-8. PubMed ID: 21482072
    [Abstract] [Full Text] [Related]

  • 13. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007 Oct 22; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B, Li P, Lv H, Li Y, Wang O, Xing XP, Qian JM.
    J Dig Dis; 2014 Mar 22; 15(3):116-23. PubMed ID: 24354597
    [Abstract] [Full Text] [Related]

  • 15. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
    Klaus J, Reinshagen M, Adler G, Boehm B, von Tirpitz C.
    BMC Gastroenterol; 2008 Oct 23; 8():48. PubMed ID: 18947388
    [Abstract] [Full Text] [Related]

  • 16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov 23; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I, Chlebna-Sokół D, Rusińska A, Jakubowska-Pietkiewicz E, Kulińska-Szukalska K.
    Ortop Traumatol Rehabil; 2008 Nov 23; 10(6):602-12. PubMed ID: 19153549
    [Abstract] [Full Text] [Related]

  • 18. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
    Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):607-14. PubMed ID: 15352908
    [Abstract] [Full Text] [Related]

  • 19. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M.
    Eur J Gastroenterol Hepatol; 2007 Dec 15; 19(12):1075-81. PubMed ID: 17998832
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
    Mir A, Minguez M, Tatay J, Pascual I, Peña A, Sanchiz V, Almela P, Mora F, Benages A.
    Am J Gastroenterol; 2002 Jun 15; 97(6):1452-7. PubMed ID: 12094864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.